Navigation Links
Lyophilization Services of New England Completes FDA Inspection

MANCHESTER, N.H., Jan. 8, 2014 /PRNewswire/ -- Lyophilization Services of New England (LSNE), a New Hampshire based contract manufacturing organization is pleased to announce that the Food and Drug Administration (FDA) recently completed an inspection of their Manchester manufacturing facility.  This is the sixth successful inspection of the site, which is currently functioning as a multiproduct medical device manufacturing facility.  The November 2013 inspection was a combination FDA general GMP and Pre-approval inspection.  The inspection resulted in no Form 483 being issued, as there were no observations noted by FDA.

Matthew Halvorsen, President and Chief Executive Officer of LSNE stated, "We are very pleased with the result of the latest FDA inspection, which adds to our successful regulatory history.  LSNE is committed to maintaining the highest level of quality across our three manufacturing sites so that we can remain a reliable partner to our clients."

This FDA inspection follows a successful MHRA inspection of the LSNE 25 Commerce Drive, Bedford NH contract pharmaceutical manufacturing facility in which LSNE received a Certificate of GMP Compliance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to manufacture aseptic lyophilized drug products for use in the European Union.

About LSNE Contract Manufacturing

LSNE Contract Manufacturing is a privately held company with three GMP facilities located in New England.   LSNE has been providing contract lyophilization services to the pharmaceutical, biotechnology and medical device industries since 1997, specializing in a wide range of services including cycle development, cGMP fill/finish, and lyophilization.  Through the thoughtful integration of three processing facilities, qualified staffing, and an extensive manufacturing history, LSNE is strategically positioned to provide uninterrupted manufacturing for clinical through commercial supply for medical device and pharmaceuticals to a multi-national market.

Media Contact
Christine Palus
Vice President of Sales & Marketing
(603) 668-5763

SOURCE Lyophilization Services of New England
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
2. Improving the Quality and Effectiveness of Marketing Services Groups in an Environment Characterized by Globalization and Shrinking Resources
3. inviCRO hires Stefan Linehan as Director of Ex Vivo Research & Imaging Services
4. Clayton, Dubilier & Rice to Invest in PharMEDium, Nations Leading Provider of Sterile Compounding Services to Hospital Pharmacies
5. Smithers Quality Assessments Expands Certification Services to Include Pharmaceuticals Industry
6. Cord Blood Banking Services Market is Expected to Reach USD 15.2 Billion Globally in 2019: Transparency Market Research
7. Indegene launches a complete range of MCM services specifically focused on integrated brand-product promotions.
8. Genpact and AstraZeneca Extend Finance and Accounting Services Agreement
9. Liquidity Services Delivers Surplus Asset Solutions in Support of Hoffmann-La Roches Consolidation Initiative
10. Numotion Acquires the Custom Mobility Division of Barnes Healthcare Services
11. PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma
Post Your Comments:
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):